Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes

Kidney International

Volumn 89, Issue 2, 2016, Pages 459-467

  Nowak, Natalia ^a,b,c   Skupien, Jan ^a,b,c   Niewczas, Monika A ^a,b   Yamanouchi, Masayuki ^a,b   Major, Melissa ^a   Croall, Stephanie ^a   Smiles, Adam ^a   Warram, James H ^a   Bonventre, Joseph V ^b,d   Krolewski, Andrzej S ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

early progressive renal decline; markers of glomerular and tubular damage; type 1 diabetes

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; HEMOGLOBIN A1C; IMMUNOGLOBULIN G2; KIDNEY INJURY MOLECULE 1; BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY INJURY; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; KIDNEY; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; URINE;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MIDDLE AGED;

EID: 84945564869     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.314     Document Type: Article

References (34)

1. E.T. Rosolowsky, J. Skupien, A.M. Smiles, and et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection J Am Soc Nephrol 22 2011 545 553
2. C. Forsblom, V. Harjutsalo, L.M. Thorn, and et al. FinnDiane Study Group. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria J Am Soc Nephrol 22 2011 537 544
3. A.S. Krolewski Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes Diabetes Care 38 2015 1 9
4. B.A. Perkins, L.H. Ficociello, B.E. Ostrander, and et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes J Am Soc Nephrol 18 2007 1353 1361
5. A.S. Krolewski, M.A. Niewczas, J. Skupien, and et al. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria Diabetes Care 37 2014 226 234
6. J. Skupien, J.H. Warram, A.M. Smiles, and et al. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of endstage renal disease Kidney Int 82 2012 589 597
7. M.A. Niewczas, L.H. Ficociello, A.C. Johnson, and et al. Serum concentrations of TNFa and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes Clin J Am Soc Nephrol 4 2008 62 70
8. T. Gohda, M.A. Niewczas, L.H. Ficociello, and et al. Circulating TNF receptors 1 and 2 predict stage 3 of CKD in type 1 diabetes J Am Soc Nephrol 23 2012 516 525
9. E.T. Rosolowsky, L.H. Ficociello, N.J. Maselli, and et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes Clin J Am Soc Nephrol 3 2008 706 713
10. L.H. Ficociello, E.T. Rosolowsky, M.A. Niewczas, and et al. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up Diabetes Care 33 2010 1337 1343
11. M. Mauer, B. Zinman, R. Gardiner, and et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes N Engl J Med 361 2009 40 51
12. T. Gohda, W.H. Walker, P. Wolkow, and et al. Elevated urinary excretion of immunoglobulins in non-proteinuric patients with type 1 Diabetes Am J Physiol Renal Physiol 303 2012 F157 F162
13. T. Ichimura, J.V. Bonventre, V. Bailly, and et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury J Biol Chem 13 1993 4135 4142
14. V. Bailly, Z. Zhang, W. Meier, and et al. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration J Biol Chem 277 2002 39739 39748
15. Z. Zhang, B.D. Humphreys, and J.V. Bonventre Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region J Am Soc Nephrol 18 2007 2704 2714
16. R. Gandhi, J. Yi, J.H. Ha, and et al. Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis Am Journal of Physiol 307 2014 F205 F221
17. V.S. Vaidya, J.S. Ozer, F. Dieterle, and et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies Nat Biotechnol 28 2010 478 485
18. V.S. Sabbisetti, S.S. Waikar, D.J. Antoine, and et al. Kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD J Am Soc Nephrol 25 2014 2177 2186
19. V.S. Vaidya, M.A. Niewczas, L.H. Ficociello, and et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl- beta-D-glucosaminidase Kidney Int 79 2011 464 470
20. O. Liangos, H. Tighiouart, M.C. Perianayagam, and et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass Biomarkers 14 2009 423 431
21. W.K. Han, S.S. Waikar, A. Johnson, and et al. Urinary biomarkers in the early diagnosis of acute kidney injury Kidney Int 73 2008 863 869
22. B.R. Conway, D. Manoharan, D. Manoharan, and et al. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors Kidney Int 82 2012 812 818
23. S.E. Nielsen, H. Reinhard, D. Zdunek, and et al. Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients Diabetes Res Clin Pract 97 2012 71 76
24. S.E. Nielsen, S. Andersen, D. Zdunek, and et al. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy Kidney Int 79 2011 1113 1118
25. N.M. Panduru, N. Sandholm, C. Forsblom, and et al. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes Diabetes Care 38 2015 1130 1137
26. G.D. Fufaa, E.J. Weil, R.G. Nelson, and et al. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus Diabetologia 58 2015 188 198
27. S.I. Araki, M. Haneda, D. Koya, and et al. Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy Diabetes Care 36 2013 1248 1253
28. N.M. Panduru, C. Forsblom, M. Saraheimo, and et al. Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes Diabetes Care 36 2013 2077 2083
29. K.M. Chou, C.C. Lee, C.H. Chen, and et al. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients PLoS One 8 2013 e54863
30. S.E. Nielsen, T. Sugaya, P. Hovind, and et al. Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients Diabetes Care 33 2010 1320 1324
31. B.D. Humphreys, F. Xu, V. Sabbisetti, and et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis J Clin Invest 123 2013 4023 4035
32. L.A. Inker, C.H. Schmid, H. Tighiouart, et al. for the CKD-EPI Investigators Estimating glomerular filtration rate from serum creatinine and cystatin C N Engl J Med 367 2012 20 29
33. B.A. Perkins, R.G. Nelson, B.E. Ostrander, and et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study J Am Soc Nephrol 16 2005 1404 1412
34. R.D. Lindeman, J. Tobin, and N.W. Shock Longitudinal studies on the rate of decline in renal function with age J Am Geriatr Soc 33 1985 278 285